NCT00326716 - Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

August 31, 2009

Conditions

HIV Infection

Interventions

DRUG

Atazanavir + Ritonavir + Combivir

Capsules, tablets, Oral, initially ATV 300 mg + RTV 100 mg + ZDV/3TC 300/150 mg, dose escalated to ATV 400 mg + RTV 100 mg + ZDV/3TC 300/150 mg, ATV and RTV once daily, lamivudine (ZDV) / zidovudine (3TC) twice daily (BID), up to 36 weeks

Trial Locations (6)

2001

Local Institution, Soweto

2092

Local Institution, Westdene

33401

Triple O Medical Services, P.A., West Palm Beach

77054

Women's Hospital Of Texas, Houston

00936

Local Institution, San Juan

0002

Local Institution, Sunnyside